Should JAK inhibitors be avoided in patients with a recent history of melanoma?

Given the FDA-boxed warning about risk of malignancy, JAK inhibitors should be used with extreme caution in patients with a recent history of malignancy, including melanoma. It would be important to have an extensive conversation with the patient to ensure understanding of the potential risks, with ...